FDA 503B outsourcing facilities in Arizona
Arizona has 3 FDA-registered 503B outsourcing facilities in the PeptideGrids directory, 3 with FDA drug recalls on record, the earliest registered in 2018. 503B facilities compound sterile medications in bulk under FDA cGMP standards and are a primary supply route for compounded peptides and GLP-1s during drug shortages.
| Facility | City | FDA-registered since | FDA recalls |
|---|---|---|---|
| Central Admixture Pharmacy Services | Phoenix | 2018 | 345 |
| Tailstorm Health Inc. | Chandler | 2019 | 8 |
| Tailstorm Health Inc. | Phoenix | 2019 | 8 |
503B compounding in Arizona
A 503B outsourcing facility registers with the FDA under the Drug Quality and Security Act and is inspected against cGMP manufacturing standards. In addition to that federal registration, a facility shipping into or operating in Arizona must hold the appropriate state pharmacy license. Verify any facility's current license with the Arizona State Board of Pharmacy.
Peptides and GLP-1s compounded in Arizona
Facilities in Arizona report compounding Oxytocin, Semaglutide, Tirzepatide to the FDA. PeptideGrids grades the clinical evidence for each. Browse the full GLP-1 and therapeutic peptide databases.
Frequently asked questions
How many FDA 503B outsourcing facilities are in Arizona?
3 FDA-registered 503B outsourcing facilities are listed in Arizona on PeptideGrids, the earliest registered in 2018.
Which Arizona 503B facilities have FDA recalls on record?
3 of the 3 Arizona facilities have FDA drug recalls on record; the table above shows the count per facility.
How do I verify a pharmacy license in Arizona?
Use the Arizona State Board of Pharmacy license lookup to confirm a facility's current license status.
Facilities sourced from the FDA registered outsourcing facilities list. Recall counts from the FDA openFDA drug enforcement database.